Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets

INTRODUCTION: Hepatocellular carcinoma (HCC) is an aggressive malignancy with steadily increasing incidence rates worldwide and poor therapeutic outcomes. Studies show that metabolic reprogramming plays a key role in tumor genesis and progression. In this study, we analyzed the metabolic heterogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zehua, Chen, Qingfeng, He, Wanrong, Cao, Junyue, Yao, Shunhan, Huang, Qingqiang, Zheng, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017446/
https://www.ncbi.nlm.nih.gov/pubmed/36937389
http://dx.doi.org/10.3389/fonc.2023.1086604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017446/
https://www.ncbi.nlm.nih.gov/pubmed/36937389
http://dx.doi.org/10.3389/fonc.2023.1086604

Ejemplares similares